TY  - JOUR
AU  - Roa-Chamorro, Ricardo
AU  - Jaén-Águila, Fernando
AU  - Puerta-Puerta, José Manuel
AU  - Torres-Quintero, Lucía
AU  - González-Bustos, Pablo
AU  - Mediavilla-García, Juan Diego
PY  - 2021
DO  - 10.1038/s41598-021-94127-2
UR  - http://hdl.handle.net/10668/18229
T2  - Scientific reports
AB  - Treatment of chronic myeloid leukaemia (CML) is based on tyrosine kinase inhibitors (TKI), whose introduction in 2001 improved the survival rate after 5 years from 40 to 90%. The longevity increase has been accompanied by a higher incidence of...
LA  - en
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Blood Pressure Monitoring, Ambulatory
KW  - Cardiovascular Diseases
KW  - Cross-Sectional Studies
KW  - Female
KW  - Heart Disease Risk Factors
KW  - Humans
KW  - Hypertension
KW  - Leukemia, Myelogenous, Chronic, BCR-ABL Positive
KW  - Male
KW  - Middle Aged
KW  - Protein Kinase Inhibitors
KW  - Spain
TI  - Arterial hypertension assessment in a population with chronic myeloid leukemia.
TY  - research article
VL  - 11
ER  -